500 related articles for article (PubMed ID: 27447477)
1. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
[TBL] [Abstract][Full Text] [Related]
2. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
[TBL] [Abstract][Full Text] [Related]
3. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
[TBL] [Abstract][Full Text] [Related]
5. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
[TBL] [Abstract][Full Text] [Related]
6. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.
Lee TY; Choi JS; Oh HC; Song TJ; Do JH; Cheon YK
Korean J Intern Med; 2015 Sep; 30(5):602-9. PubMed ID: 26354054
[TBL] [Abstract][Full Text] [Related]
7. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis.
Khoshbaten M; Khorram H; Madad L; Ehsani Ardakani MJ; Farzin H; Zali MR
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e11-6. PubMed ID: 17683501
[TBL] [Abstract][Full Text] [Related]
8. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial.
Park SW; Chung MJ; Oh TG; Park JY; Bang S; Park SW; Song SY
Endoscopy; 2015 Jan; 47(1):33-9. PubMed ID: 25409167
[TBL] [Abstract][Full Text] [Related]
11. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study.
Geraci G; Palumbo VD; D'Orazio B; Maffongelli A; Fazzotta S; Lo Monte AI
Clin Ter; 2019; 170(5):e332-e336. PubMed ID: 31612188
[TBL] [Abstract][Full Text] [Related]
12. Does melatonin addition to indomethacin decrease post endoscopic retrograde cholangiopancreatography pancreatitis? A randomized double-blind controlled trial.
Sadeghi A; Abbasinazari M; Asadzadeh Aghdaei H; Abdi S; Hatami B; Rasoolinezhad M; Jamshidzadeh S; Saadati S
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1350-1355. PubMed ID: 31524774
[TBL] [Abstract][Full Text] [Related]
13. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
14. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitroglycerin as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.
Tomoda T; Kato H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Matsumoto K; Yamamoto N; Horiguchi S; Tsutsumi K; Okada H
Acta Med Okayama; 2016 Octoaber; 70(5):405-408. PubMed ID: 27777436
[TBL] [Abstract][Full Text] [Related]
15. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.
Patai Á; Solymosi N; Mohácsi L; Patai ÁV
Gastrointest Endosc; 2017 Jun; 85(6):1144-1156.e1. PubMed ID: 28167118
[TBL] [Abstract][Full Text] [Related]
18. Diclofenac is associated with a reduced incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: results from a Danish cohort study.
Leerhøy B; Nordholm-Carstensen A; Novovic S; Hansen MB; Jørgensen LN
Pancreas; 2014 Nov; 43(8):1286-90. PubMed ID: 25003219
[TBL] [Abstract][Full Text] [Related]
19. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.
Murray B; Carter R; Imrie C; Evans S; O'Suilleabhain C
Gastroenterology; 2003 Jun; 124(7):1786-91. PubMed ID: 12806612
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]